This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
between 18 and 80
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

The purpose of the trial is to study the safety and the effectiveness of using CT Perfusion studies as an indicator to treat stroke patients with unknown time of onset.

Provided treatments

  • Drug: Anti-platelets and statin
  • Drug: alteplase
  • Procedure: intra arterial intervention

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01455935. The sponsor of the trial is Jacobs Neurological Institute and it is looking for 90 volunteers for the current phase.
Official trial title:
Wake up Symptomatic Stroke in Acute Brain Ischemia (WASSABI) Trial